Scientific notes

Melanoma Immunotherapy and Precision Medicine in the Era of Tumor Micro-Tissue Engineering: Where Are We Now and Where Are We Going?

Introduction

Melanoma is clearly a complex disease with a high degree of heterogeneity and adaptability. Melanoma cells are part of a larger ecosystem in which the tumor microenvironment influences their evolution and ability to evade medication therapy. In order to acquire a better knowledge of the mechanisms behind melanoma biology and therapeutic resistance, various efforts have lately been directed toward the development of ex-vivo models capable of replicating the living conditions of melanoma cells in real patients.
The researcher has created and applied a novel approach that uses complex 3D models in microfluidic systems to replicate the melanoma immune microenvironment.

How to culture vascularized & immunocompetent 3D models in a standard Multiwell

Abstract

The authors state that “Malignant melanoma still remains a cancer with very poor survival rates, although it is at the forefront of personalized medicine. Most patients show partial responses and disease progressed due to adaptative resistance mechanisms, preventing long-lasting clinical benefits to the current treatments.

The response to therapies can be shaped by not only taking into account cancer cell heterogeneity and plasticity but also by its structural context as well as the cellular component of the tumor microenvironment (TME).

Here, we review the recent development in the field of immunotherapy and target-based therapy and how, in the era of tumor micro-tissue engineering, ex-vivo assays could help to enhance our melanoma biology knowledge in its complexity, translating it into the development of successful therapeutic strategies, as well as in the prediction of therapeutic benefits.”.

References

Varrone F, Mandrich L, Caputo E. Melanoma Immunotherapy and Precision Medicine in the Era of Tumor Micro-Tissue Engineering: Where Are We Now and Where Are We Going? Cancers (Basel). 2021 Nov 18;13(22):5788. doi: 10.3390/cancers13225788. PMID: 34830940; PMCID: PMC8616100.

Related Posts

From an organ on a chip to a body on a chip...
Scaling up organs on a chip to get a functional body on a chip Recent innovations in microfluidic technologies have produced organ on a chi...
Read more
Scientific Poster – Skin sensitization and safety assessment ba...
SCIENTIFIC POSTER DOWLOAD — Skin sensitization and safety assessment based on an in vitro 3D vascularized fully differentiated immunocompe...
Read more
Figure1-3D-liver-cell-culture-liver-on-a-chip-structure-liver
The Complexity Behind the 3D Cell Cultures: the 3D Liver Cell Cul...
Introduction Once it is clear how to deal with 3D cell cultures it is time to focus on one type of cell and analyze its strengths and its li...
Read more

get in touch

Get the best insights about Cherry Biotech by Email Let’s stay in touch!
As part of our commercial prospecting, we may need to process your personal data. For more information, please consult our Privacy Policy